NCT Number: NCT07439146
Orotracheal intubation in emergency medicine is a vital procedure for ensuring adequate oxygenation and ventilation in patients with respiratory distress or in shock. However, this procedure exposes patients to complications such as pneumonia. In the matter of fact, the urgency of the procedure means that it is not possible to wait until the patient's stomach is empty. Pneumonia significantly increase patient morbidity and mortality. Therapeutic management must be early and appropriate to improve the patient's prognosis.
The aim of this study is to compare the rate of pneumonia occurring in patients intubated in emergency situations with that in patients intubated in non-emergency situations in all 2024. Health data will only collected from patient's medical records.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
CH Aurillac, Aurillac, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Hour 48
Rate of pneumonia occuring within 48 hours of the start of orotracheal intubation.
Time frame: 3 months
Rate of pneumonia occuring more than 48 hours after the start of orotracheal intubation.
Time frame: Up to the end of mechanical ventilation (assessed up to 1 month)
Duration of mechanical ventilation
Time frame: Up to intensive care discharge (assessed up to 1 month)
Duration of stay in intensive care
Time frame: Up to hospital discharge (assessed up to 3 months)
Duration of hospital stay
Time frame: Inclusion + 1 year
Mortality rate
Time frame: The day of the diagnosis of pneumonia (assessed up to 1 month)
The bacterial species responsible for pneumonia will be identified using biological samples (blood, urine, bronchial secretions) taken from patients in both groups. The identification of bacterial species will be carried out in the laboratory.
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Type of antibiotic administered for pneumonia in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Comparison of antibiotic doses in g or mg administered in each group
Time frame: Up to the last day of antibiotic treatment (assessed up to 3 months)
Duration of antibiotic treament for pneumonia in each group
Contact information is provided by the study sponsor or research team.
University Hospital, Clermont-Ferrand
Other
Acronym: PNEUMIOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07708610
Diabetes Mellitus, Diabetes Mellitus, Type 2
Taichung, Taiwan
View Trial DetailsNCT07703852
Infections, Lung Diseases
View Trial DetailsNCT07631377
Actinomycetales Infections, Antibiotic Resistant Strain
View Trial DetailsNCT07634419
ARDS, Accidental Injuries
Los Angeles, California, United States
View Trial Details